Exenatide Once Weekly: Effectiveness, Tolerability, and Discontinuation Predictors in a Real-world Setting-Reference-Cited by-同舟云学术

Exenatide Once Weekly: Effectiveness, Tolerability, and Discontinuation Predictors in a Real-world Setting

Published:2020-09 Issue:9 Volume:42 Page:1738-1749.e1
ISSN:0149-2918
Container-title:Clinical Therapeutics
language:en
Short-container-title:Clinical Therapeutics

Author:

Di Dalmazi Giulia^ORCID,Coluzzi Sara^ORCID,Baldassarre Maria P.A.^ORCID,Sorbo Sofia Elena,Dell’Aquila Stefania,Febo Fabrizio,Ginestra Federica,Graziano Giusi,Rossi Maria C.,Consoli Agostino,Formoso Gloria^ORCID

Funder

AstraZeneca

Novo Nordisk

Eli Lilly

Boehringer Ingelheim

Merck Sharp & Dohme

Sanofi Aventis

Menarini Diagnostics

Roche Diagnostics

Takeda

Menarini Diagnostic

Mundipharma

Sanofi

Alfasigma

Medtronic

Artsana

Johnson & Johnson

Publisher

Elsevier BV

Subject

Pharmacology (medical),Pharmacology

Reference42 articles.

1. Management of endocrine disease: are all GLP-1 agonists equal in the treatment of type 2 diabetes?;Nauck;Eur J Endocrinol,2019

2. A comparative safety review between GLP-1 receptor agonists and SGLT2 inhibitors for diabetes treatment;Consoli;Expert Opin Drug Saf,2018

3. Cardiovascular outcomes with glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes mellitus: a systematic review and meta-analysis;Pulipati;Eur J Prev Cardiol,2020

4. Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials;Kristensen;Lancet Diabetes Endocrinol,2019

5. 2019 update to: management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD);Buse;Diabetologia,2020

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparison of exenatide alone or combined with metformin versus metformin in the treatment of polycystic ovaries: a systematic review and meta-analysis;BMC Endocrine Disorders;2023-11-16

2. Treatment effect heterogeneity following type 2 diabetes treatment with GLP1-receptor agonists and SGLT2-inhibitors: a systematic review;Communications Medicine;2023-10-05

3. Safety and effectiveness of dulaglutide in Chinese adults with type 2 diabetes mellitus in a real‐world setting: A prospective, observational post‐marketing study;Diabetes, Obesity and Metabolism;2023-08-23

4. Precision medicine in type 2 diabetes: A systematic review of treatment effect heterogeneity for GLP1-receptor agonists and SGLT2-inhibitors;2023-04-22

5. Effectiveness and Tolerability of Once-Weekly GLP-1 Receptor Agonists in Clinical Practice: A Focus on Switching Between Once-Weekly Molecules in Type 2 Diabetes;Frontiers in Endocrinology;2022-07-15